Table 2.
Antimicrobial prophylaxis in children undergoing allogeneic hematopoietic cell transplantation.
| Phase | Antibacterial | Antiviral | Pnemocystis/toxoplasmosis | Antifungal | IVIG |
|---|---|---|---|---|---|
| Conditioning | NGR | NGR | NGR | NGR | NGR |
| Pre-engraftment | NGR | aciclovir | NGR | L-AmB, azoles or echinocandins | NGR |
| Post-engraftment w/o a/c GvHD | NGR | aciclovir | SMX/TMP | NGR | NGR |
| Post-engraftment with a/c GvHD | PNC | aciclovir | SMX/TMP | azoles or echinocandins | NGR |
NGR, not generally recommended; PNC, penicillin; SMX/TMP, sulfamethoxazole/trimethoprim; L-AmB, intravenous liposomal amphotericin B; IVIG, intravenous immunoglobulin.
If IgG levels below 400 mg/dL IVIG could be given. a/c GvHD, acute or chronic graft vs host disease.